Last 46.35 INR
Change Today -2.45 / -5.02%
Volume 1.8K
ICP On Other Exchanges
Symbol
Exchange
ICP is not on other exchanges.
As of 3:54 AM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

iol chemicals and pharma ltd (ICP) Snapshot

Open
47.50
Previous Close
48.80
Day High
48.50
Day Low
46.35
52 Week High
06/13/14 - 60.60
52 Week Low
08/6/13 - 14.65
Market Cap
1.3B
Average Volume 10 Days
10.2K
EPS TTM
1.85
Shares Outstanding
28.8M
EX-Date
02/28/97
P/E TM
25.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for IOL CHEMICALS AND PHARMA LTD (ICP)

Related News

No related news articles were found.

iol chemicals and pharma ltd (ICP) Related Businessweek News

No Related Businessweek News Found

iol chemicals and pharma ltd (ICP) Details

IOL Chemicals and Pharmaceuticals Limited is engaged in the manufacture and supply of bulk drugs, food additives, reactants, and solvents in India and internationally. The company’s products include glacial acetic acid and acetic acid, an organic compound; ethyl acetate, a colorless liquid ester; acetic anhydride, an acid anhydride; ibuprofen, a non-steroidal anti-inflammatory drug; isobutyl benzene, a specialty chemical that is used as an intermediate in the preparation of various pharmaceutical compositions and the perfume industry, and as a specialty solvent; mono chloro acetic acid for the production of pharmaceuticals, insecticides, and other agrochemicals; and acetyl chloride, which is used as pharmaceutical bulk drugs and intermediates. Its products also comprise omeparazole, lansoprazole, rabeprazole sodium, tramadol HCl, sertraline HCl, losartan potassium, lamotrigine, fenofibrate, and pantoprazole Na sesquihyderate/pantoprazole sodium. The company also offers raw materials, such as active reactants, catalysts, and solvents. IOL Chemicals and Pharmaceuticals Limited was founded in 1986 and is headquartered in Ludhiana, India.

Founded in 1986

iol chemicals and pharma ltd (ICP) Top Compensated Officers

Managing Director, Chief Executive Officer, D...
Total Annual Compensation: 3.1M
Joint Managing Director and Whole Time Direct...
Total Annual Compensation: 160.0K
Director of Works, Director, Member of Audit ...
Total Annual Compensation: 1.2M
Compensation as of Fiscal Year 2013.

iol chemicals and pharma ltd (ICP) Key Developments

IOL Chemicals and Pharmaceuticals Ltd., Board Meeting, Jul 04, 2014

IOL Chemicals and Pharmaceuticals Ltd., Board Meeting, Jul 04, 2014. Agenda: To consider 1,150,000 equity shares of INR 10 each at a premium of INR 18 per share to the non promoters of the company which will be locked in for a period of one year from the date of trading approval; and to consider 11,000,000 warrants to the non promoters, carrying an option to the holder of such warrants to subscribe to one equity share of INR 10 at premium of INR 18 per share for every warrant held, within 18 months from the date of allotment of the warrants.

IOL Chemicals and Pharmaceuticals Ltd. Approves Amending Clause V of Memorandum of Association

IOL Chemicals and Pharmaceuticals Ltd. at its EGM held on June 20, 2014 approved amending Clause V of memorandum of association effecting increase in authorised share capital of the company.

IOL Chemicals and Pharmaceuticals Ltd. Reports Audited Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2014

IOL Chemicals and Pharmaceuticals Ltd. reported audited earnings results for the fourth quarter and full year ended March 31, 2014. For the quarter, the company reported total income from operations (net) of INR 1,309.877 million compared to INR 1,359.098 million a year ago. Profit from operations before other income, interest and exceptional items was INR 159.654 million compared to INR 142.902 million a year ago. Profit from ordinary activities before tax was INR 9.779 million compared to INR 4.928 million a year ago. Net profit was INR 8.103 million or INR 0.28 per basic and diluted share before and after extraordinary items compared to INR 0.672 million or INR 0.03 per basic and diluted share before and after extraordinary items a year ago. For the year, the company reported total income from operations (net) of INR 5,647.900 million compared to INR 4,840.218 million a year ago. Profit from operations before other income, interest and exceptional items was INR 654.082 million compared to INR 601.802 million a year ago. Profit from ordinary activities before tax was INR 50.823 million compared to INR 29.584 million a year ago. Net profit was INR 32.994 million or INR 1.21 per basic and diluted share before and after extraordinary items compared to INR 15.886 million or INR 0.61 per basic and diluted share before and after extraordinary items a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ICP:IN 46.35 INR -2.45

ICP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ICP.
View Industry Companies
 

Industry Analysis

ICP

Industry Average

Valuation ICP Industry Range
Price/Earnings 39.6x
Price/Sales 0.2x
Price/Book 0.7x
Price/Cash Flow 5.4x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IOL CHEMICALS AND PHARMA LTD, please visit www.iolcp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.